Exact Mass: 452.1067

Exact Mass Matches: 452.1067

Found 74 metabolites which its exact mass value is equals to given mass value 452.1067, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cinchonain Ib

(2R) -2alpha,10beta-Bis (3,4-dihydroxyphenyl) -3alpha,5-dihydroxy-3,4,9,10-tetrahydro-2H,8H-benzo [ 1,2-b:3,4-b ] dipyran-8-one

C24H20O9 (452.1107)

6,12-bis(3,4-dihydroxyphenyl)-8,13-dihydroxy-3,11-dioxatricyclo[8.4.0.0(2),]tetradeca-1(10),2(7),8-trien-4-one

C24H20O9 (452.1107)

(-)-Epigallocatechin 3-p-coumaroate

(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl (2E)-3-(4-hydroxyphenyl)prop-2-enoate

C24H20O9 (452.1107)

(-)-Epigallocatechin 3-p-coumaroate is found in tea. (-)-Epigallocatechin 3-p-coumaroate is isolated from leaves of green tea (Thea sinensis). Isolated from leaves of green tea (Thea sinensis). Epigallocatechin 3-p-coumarate is found in tea.

Nüzhendic acid

2-[3-(carboxymethyl)-3-hydroxy-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydropyran-4-yl]acetic acid

C17H24O14 (452.1166)

CONFIDENCE standard compound; EAWAG_UCHEM_ID 2778

MCULE-4478526130

C19H18F6N2O2S (452.0993)

C24H20O9

C24H20O9 (452.1107)

4-methoxy-3,5,7-trihydroxy-8-(1-(3,4,5-trihydroxyphenyl)ethyl)flavone

C24H20O9 (452.1107)

3-methoxy-5-demethoxycadensin G

C24H20O9 (452.1107)

SCHEMBL14805569

C24H20O9 (452.1107)

Nuezhenidic acid

C17H24O14 (452.1166)

Flavomentin D

C24H20O9 (452.1107)

Cys Cys Asn Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C14H24N6O7S2 (452.1148)

Cys Asn Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C14H24N6O7S2 (452.1148)

Cys Asn Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C14H24N6O7S2 (452.1148)

Asn Cys Cys Asn

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C14H24N6O7S2 (452.1148)

Asn Cys Asn Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C14H24N6O7S2 (452.1148)

Asn Asn Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H24N6O7S2 (452.1148)

9,10-Dihydro-10-(3,4-dihydroxyphenyl)-pyrano[2,3-h]catechin-8-one

C24H20O9 (452.1107)

Cinchonain Ic

C24H20O9 (452.1107)

Epigallocatechin 3-O-p-coumarate

C24H20O9 (452.1107)

1,1-((1,4-phenylenebis(oxy))bis(4,1-phenylene))bis(1H-pyrrole-2,5-dione)

C26H16N2O6 (452.1008)

N-(6-((4,5-DICYANO-1-METHYL-1H-IMIDAZOL-2-YL)DIAZENYL)-1-METHYL-1,2,3,4-TETRAHYDROQUINOLIN-7-YL)-1,1,1-TRIFLUOROMETHANESULFONAMIDE

C17H15F3N8O2S (452.0991)

LY-487379

C21H19F3N2O4S (452.1018)

LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [35S]GTPγS binding with EC50 values of 1.7 μM and >10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes cognitive flexibility and facilitates behavioral inhibition in a rat model. LY487379 can be used for schizophrenia research[2].

[(1R,2R,3R,4S)-1,3-diacetyloxy-2,4,9-trihydroxy-2-methyl-5,10-dioxo-3,4-dihydro-1H-benzo[b]fluoren-11-ylidene]methylideneazanide

C23H18NO9- (452.0982)

2-[4-(Benzenesulfonyl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole

C23H20N2O6S (452.1042)

2-[[4-(4-fluorophenyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]thio]-N-[(2-furanylmethylamino)-oxomethyl]acetamide

C21H17FN6O3S (452.1067)

N-[2,6-bis(4-morpholinyl)-4-pyrimidinyl]-3,4-dichlorobenzohydrazide

C19H22Cl2N6O3 (452.113)

N-[2,6-bis(4-morpholinyl)-4-pyrimidinyl]-2,4-dichlorobenzohydrazide

C19H22Cl2N6O3 (452.113)

2-[4-Chloro-2-[3-(4-methoxyphenyl)-4-oxo-1,2-dihydroquinazolin-2-yl]phenoxy]acetic acid methyl ester

C24H21ClN2O5 (452.1139)

2-{[(4-{[2-(4-Chloro-2-methylphenoxy)propanoyl]amino}phenyl)carbonyl]amino}benzoic acid

C24H21ClN2O5 (452.1139)

Xanthonolignoid A B676297K281

C24H20O9 (452.1107)

cyclohex-1,4-dienecarboxyl-AMP

C17H19N5O8P- (452.0971)

cyclohex-2,5-dienecarboxyl-AMP

C17H19N5O8P- (452.0971)

4-[2,5-dimethyl-3-[(E)-(4-oxo-2-phenylimino-1,3-thiazolidin-5-ylidene)methyl]pyrrol-1-yl]benzenesulfonamide

C22H20N4O3S2 (452.0977)

Cinchonain 1a

C24H20O9 (452.1107)

ST 21:6;O6;S

C21H24O9S (452.1141)

Rovazolac

C21H19F3N2O4S (452.1018)

Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.

4,14-bis(3,4-dihydroxyphenyl)-5,8-dihydroxy-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2(7),8-trien-12-one

C24H20O9 (452.1107)

(2s,3s)-9-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-(hydroxymethyl)-12-methoxy-2,3-dihydro-1,4,5-trioxatetraphen-10-one

C24H20O9 (452.1107)

(2r,3r)-9-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1,4,5-trioxatetraphen-10-one

C24H20O9 (452.1107)

(1r,4s,5s,9r,11r,14s,15s,19r)-5,15-dihydroxy-1,11-bis(methylsulfanyl)-3,13-diazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]icos-6-ene-2,8,12,18-tetrone

C20H24N2O6S2 (452.1076)

[(2s,3s,4r)-4-(carboxymethyl)-3-hydroxy-5-(methoxycarbonyl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,4-dihydropyran-3-yl]acetic acid

C17H24O14 (452.1166)

(4R,8R,9R)-4,8-bis(3,4-dihydroxyphenyl)-5,9-dihydroxy-4,8,9,10-tetrahydro-3H-pyrano[6,5-h]chromen-2-one

C24H20O9 (452.1107)

{"Ingredient_id": "HBIN010873","Ingredient_name": "(4R,8R,9R)-4,8-bis(3,4-dihydroxyphenyl)-5,9-dihydroxy-4,8,9,10-tetrahydro-3H-pyrano[6,5-h]chromen-2-one","Alias": "NA","Ingredient_formula": "C24H20O9","Ingredient_Smile": "NA","Ingredient_weight": "452.41","OB_score": "58.1634287","CAS_id": "85081-22-7","SymMap_id": "SMIT13323","TCMID_id": "NA","TCMSP_id": "MOL012579","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-hydroxy-9-{[(2s,3r)-6-hydroxy-2-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]oxy}-10-methoxybenzo[c]chromen-6-one

C24H20O9 (452.1107)

6,12-bis(3,4-dihydroxyphenyl)-8,13-dihydroxy-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-4-one

C24H20O9 (452.1107)

(4r,5s,14s)-4,14-bis(3,4-dihydroxyphenyl)-5,8-dihydroxy-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2(7),8-trien-12-one

C24H20O9 (452.1107)

(4r,5s,14r)-4,14-bis(3,4-dihydroxyphenyl)-5,8-dihydroxy-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2(7),8-trien-12-one

C24H20O9 (452.1107)

(1r,4r,5r,9r,11r,14r,15s,19s)-5,15-dihydroxy-1,11-bis(methylsulfanyl)-3,13-diazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]icos-6-ene-2,8,12,18-tetrone

C20H24N2O6S2 (452.1076)

(4s,5s,14r)-4,14-bis(3,4-dihydroxyphenyl)-5,8-dihydroxy-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2(7),8-trien-12-one

C24H20O9 (452.1107)